These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29146242)

  • 1. Acid-activatable oxidative stress-inducing polysaccharide nanoparticles for anticancer therapy.
    Yoo W; Yoo D; Hong E; Jung E; Go Y; Singh SVB; Khang G; Lee D
    J Control Release; 2018 Jan; 269():235-244. PubMed ID: 29146242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer.
    Zhao C; Cao W; Zheng H; Xiao Z; Hu J; Yang L; Chen M; Liang G; Zheng S; Zhao C
    Int J Nanomedicine; 2019; 14():1597-1618. PubMed ID: 30880968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core-crosslinked nanomicelles based on crosslinkable prodrug and surfactants for reduction responsive delivery of camptothecin and improved anticancer efficacy.
    He W; Du Y; Zhou W; Wang T; Li M; Li X
    Eur J Pharm Sci; 2020 Jul; 150():105340. PubMed ID: 32371069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid-sensitive oxidative stress inducing and photoabsorbing polysaccharide nanoparticles for combinational anticancer therapy.
    Hong E; Hyun H; Lee H; Jung E; Lee D
    Int J Pharm; 2020 Jan; 574():118893. PubMed ID: 31765773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-sensitive prodrug conjugated polydopamine for NIR-triggered synergistic chemo-photothermal therapy.
    Zhang H; Sun Y; Huang R; Cang H; Cai Z; Sun B
    Eur J Pharm Biopharm; 2018 Jul; 128():260-271. PubMed ID: 29733952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction-responsive amphiphilic polymeric prodrugs of camptothecin-polyphosphoester for cancer chemotherapy.
    Jin H; Sun M; Shi L; Zhu X; Huang W; Yan D
    Biomater Sci; 2018 May; 6(6):1403-1413. PubMed ID: 29595843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual pH-sensitive oxidative stress generating micellar nanoparticles as a novel anticancer therapeutic agent.
    Park S; Kwon B; Yang W; Han E; Yoo W; Kwon BM; Lee D
    J Control Release; 2014 Dec; 196():19-27. PubMed ID: 25278257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery.
    Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z
    J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of small interfering RNA using a camptothecin prodrug as the carrier.
    Tang Q; Cao B; Cheng G
    Chem Commun (Camb); 2014 Feb; 50(11):1323-5. PubMed ID: 24343195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox sensitive lipid-camptothecin conjugate encapsulated solid lipid nanoparticles for oral delivery.
    Du Y; Ling L; Ismail M; He W; Xia Q; Zhou W; Yao C; Li X
    Int J Pharm; 2018 Oct; 549(1-2):352-362. PubMed ID: 30099214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy.
    Zhang F; Zhu G; Jacobson O; Liu Y; Chen K; Yu G; Ni Q; Fan J; Yang Z; Xu F; Fu X; Wang Z; Ma Y; Niu G; Zhao X; Chen X
    ACS Nano; 2017 Sep; 11(9):8838-8848. PubMed ID: 28858467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid Tumors.
    Nguyen F; Guan P; Guerrero DT; Kolla V; Naraparaju K; Perry LM; Soberman D; Pressly BB; Alferiev IS; Chorny M; Brodeur GM
    Cancer Res; 2020 Oct; 80(19):4258-4265. PubMed ID: 32839252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumor activity of a self-assembling camptothecin and capecitabine hybrid prodrug for improved efficacy.
    Ma W; Su H; Cheetham AG; Zhang W; Wang Y; Kan Q; Cui H
    J Control Release; 2017 Oct; 263():102-111. PubMed ID: 28082170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies.
    Zhang H; Wang J; Mao W; Huang J; Wu X; Shen Y; Sui M
    J Control Release; 2013 Mar; 166(2):147-58. PubMed ID: 23266448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-Responsive Micellar Nanoparticles for the Delivery of a Self-Amplifying ROS-Activatable Prodrug.
    Kannaujiya VK; Qiao Y; Sheikh RH; Xue J; Dargaville TR; Liang K; Wich PR
    Biomacromolecules; 2024 Mar; 25(3):1775-1789. PubMed ID: 38377594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymersome nanoreactors with tumor pH-triggered selective membrane permeability for prodrug delivery, activation, and combined oxidation-chemotherapy.
    Mukerabigwi JF; Yin W; Zha Z; Ke W; Wang Y; Chen W; Japir AAMM; Wang Y; Ge Z
    J Control Release; 2019 Jun; 303():209-222. PubMed ID: 31026547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
    J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapy.
    Li Y; Liu R; Yang J; Ma G; Zhang Z; Zhang X
    Biomaterials; 2014 Dec; 35(36):9731-45. PubMed ID: 25189519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid-responsive endosomolytic polymeric nanoparticles with amplification of intracellular oxidative stress for prodrug delivery and activation.
    Lu N; Xi L; Zha Z; Wang Y; Han X; Ge Z
    Biomater Sci; 2021 Jun; 9(13):4613-4629. PubMed ID: 34190224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.